| Recruitment status | Terminated |
| Unique ID issued by UMIN | UMIN000002585 |
| Receipt No. | R000002948 |
| Official scientific title of the study | Analysis of coagulability and coagulation factors before and after the development of symptoms in patients with physical urticaria |
| Date of disclosure of the study information | 2009/10/05 |
| Last modified on | 2018/05/07 (Ver. 18) |
| Basic information | ||
| Official scientific title of the study | Analysis of coagulability and coagulation factors before and after the development of symptoms in patients with physical urticaria | |
| Title of the study (Brief title) | Coagulability and coagulation factors before and after the development of urticaria | |
| Region |
|
|
| Condition | ||
| Condition | physical urticaria | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To study the involvement of the coagulation pathway in the pathogenesis of physical urticaria, we investigate coagulability, coagulation factors and levels of blood histamine before and after the development of symptoms in patients with physical urticaria. |
| Basic objectives2 | Others |
| Basic objectives -Others | Investigation of the pathogenesis |
| Trial characteristics_1 | Exploratory |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | Measurements regarding coagulability, coagulation factors and levels of blood histamine before and after the development of symptoms |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Prevention | |
| Type of intervention |
|
|
| Interventions/Control_1 | The provocation of urticarial symptoms | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Patients with physical urticaria who
1. are not less than 20 years old (no upper limit) 2. gave written informed consent |
|||
| Key exclusion criteria | 1. Pregnant or lactating women or women of child bearing potential not using contraception
2. Patients with diseases as follows. Liver disease, psychological illness, convulsive and other seizure, heart disease, hemoglobinopathy, hemophilia, uncontrolled diabetes, and autoimmune diseases. 3. Patients who use medications that influence the coagulation and fibrinolytic cascade. 4. Others whom the physician judges are not suitable as subjects |
|||
| Target sample size | 20 | |||
| Research contact person | |
| Name of lead principal investigator | Michihiro Hide |
| Organization | Hiroshima University Hospital |
| Division name | Department of Dermatology |
| Address | 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551 |
| TEL | 082-257-5237 |
| ed1h-w1de-road@hiroshima-u.ac.jp | |
| Public contact | |
| Name of contact person | Satoshi Morioke |
| Organization | Hiroshima University Hospital |
| Division name | Department of Dermatology |
| Address | 1-2-3 Kasumi, Minami-ku, Hiroshima 734-8551 |
| TEL | 082-257-5237 |
| Homepage URL | |
| morioke-hma@hiroshima-u.ac.jp | |
| Sponsor | |
| Institute | Department of Dermatology, Hiroshima University Hospital |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Self funding |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Terminated | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date |
|
||||||
| Date of closure to data entry |
|
||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000002948 |